Treating periprosthetic joint infections as biofilms: key diagnosis and management strategies

Area of Science:

• Microbiology
• Biomedical Engineering
• Infectious Diseases

Background:

• Microbial biofilms are implicated in periprosthetic joint infection (PJI) pathogenesis.
• Biofilm bacteria exhibit enhanced immune evasion and antibiotic resistance compared to planktonic forms.
• Current PJI diagnosis and treatment face challenges due to biofilm properties.

Purpose of the Study:

• To review advances in diagnosing and treating biofilm-associated PJI.
• To highlight emerging technologies for PJI management.
• To discuss the integration of new methods into PJI clinical guidelines.

Main Methods:

• Review of current PJI guidelines.
• Analysis of culture-independent diagnostic techniques (e.g., 16S rRNA gene sequencing).
• Evaluation of novel antibiofilm therapeutic strategies (e.g., quorum quenchers, bacteriophages, physical disruption methods).

Main Results:

• Culture-independent methods offer higher throughput and sensitivity for PJI diagnosis.
• Novel therapies target biofilm-specific properties for improved eradication.
• Emerging technologies show potential to enhance PJI treatment efficacy and reduce costs.

Conclusions:

• Biofilm infections in PJI are difficult to detect and treat with conventional methods.
• Molecular diagnostics and next-generation antibiofilm treatments are crucial for future PJI management.
• Integration of these advanced techniques into PJI clinical guidelines is recommended.